PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
172.07%
Net income growth above 1.5x VET's 78.42%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
31.52%
Some D&A expansion while VET is negative at -2.64%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
223.75%
Lower deferred tax growth vs. VET's 494.54%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-19.28%
Both reduce yoy usage, with VET at -172.32%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-19.28%
Both reduce yoy usage, with VET at -172.32%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-233.29%
Both negative yoy, with VET at -255.45%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
39.67%
Some CFO growth while VET is negative at -22.24%. John Neff would note a short-term liquidity lead over the competitor.
-9.23%
Negative yoy CapEx while VET is 100.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-98.68%
Negative yoy acquisition while VET stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
130.15%
We have some outflow growth while VET is negative at -201.16%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
37.35%
Investing outflow well above VET's 31.49%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
99.12%
Lower share issuance yoy vs. VET's 2631.51%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.